ABOS   $2.86  7.52% Market Closed After Close 2.8996 1.38%

Acumen Pharmaceuticals Inc
Total Cash 260.47M
totalCashPerShare 4.335
EBITDA -76.61M
Total Debt 29.72M
quickRatio 16.957
currentRatio 17.369
Total Revenue
debtToEquity 12.185
Revenue/Share
ROA -0.20555
ROE -0.31425
grossProfits
freeCashflow -36.27M
operatingCashflow -55.62M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -90.76M
forwardPE -1.5620916
floatShares 32.42M
sharesOutstanding 60.08M
sharesShort 1.56M
sharesShortPriorMonth 1.69M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.11%
heldPercentInstitutions 0.78%
Short Ratio help_outline 8.91%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 4.06
Price To Book help_outline 0.59
earningsQuarterlyGrowth
netIncomeToCommon -64.86M
trailingEps -1.11%
forwardEps -1.53%
enterpriseToEbitda 1.19
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.36 3Q 2024
institutionsCount 111
lastUpdated Oct. 17, 2024, 12:05 a.m.